El Paso Texas Oncology is a clinical research site located in El Paso, Texas, United States 79902.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
El Paso Texas Oncology has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Breast Cancer, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors, Early Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
El Paso Texas Oncology has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
El Paso Texas Oncology has 3 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors, Early Breast Cancer.
El Paso Texas Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.